(Q36557802)
Statements
Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with refractory solid tumours (English)
P A Zucali
F De Vincenzo
E Lorenzi
M Perrino
M Bertossi
R Finotto
S Naimo
L Balzarini
C Bonifacio
I Timofeeva
G Rossoni
G Mazzola
A Lambiase
C Bordignon
20 November 2012
1 reference
1 reference
1 reference
1 reference
1 reference